RTW Investments’s Capricor Therapeutics CAPR Stock Holding History

RTW Investments’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.6M	Hold	250,000	–	–	0.08%	72
2025 Q4	$7.21M	Buy	+250,000	New	+$3.26M	0.07%	76

Other funds holding CAPR

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JHC

Jones Hill Capital New York $466M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RTW Investments's CAPR Position: Q1 2026 in Review

RTW Investments held its Capricor Therapeutics (CAPR) position steady in Q1 2026 at 250,000 shares worth $7.6M. The position accounts for 0.08% of the portfolio, ranked #72.

RTW Investments first reported a position in CAPR in Q4 2025 and has held it in 2 quarters since. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

RTW Investments held 250,000 shares of Capricor Therapeutics worth $7.6M as of Q1 2026.
RTW Investments left its Capricor Therapeutics share count unchanged in Q1 2026.
Capricor Therapeutics made up 0.08% of RTW Investments's portfolio in Q1 2026, its #72 holding.
RTW Investments first reported a position in Capricor Therapeutics in Q4 2025 and has held it in 2 quarters since.
177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on RTW Investments's 13F filing for Q1 2026, filed 15 May 2026.